Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway

• Үндсэн зохиолчид: Xue Tian (Зохиогч), Xu Chen (Зохиогч), Qianqian Jiang (Зохиогч), Qianbin Sun (Зохиогч), Tiantian Liu (Зохиогч), Yiqin Hong (Зохиогч), Yawen Zhang (Зохиогч), Yanyan Jiang (Зохиогч), Mingyan Shao (Зохиогч), Ran Yang (Зохиогч), Chun Li (Зохиогч), Qiyan Wang (Зохиогч), Yong Wang (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Aims: Cardiac lipotoxicity is the common consequence of lipid metabolism disorders in cardiomyocytes during development of heart failure (HF). Adenosine 5'monophosphate-activated protein kinase (AMPK) acts as an energy sensor and has a beneficial effect in reducing lipotoxicity. Notoginsenoside...